Metrion Biosciences Leaders in Ion Channel Sciences copy
Metrion Icon 01

Specialist preclinical drug discovery CRO

Ion channels • Cardiac safety • Neuroscience

Good Laboratory Practice (GLP) hERG testing service launched

Neuroscience service now includes CNS drug discovery

Metrion Upcoming Events Background scaled
Metrion Biosciences

Latest News

Metrion Biosciences appoints Dr Chris Mathes as Chief Commercial Officer

23rd July 2024

Metrion Biosciences Limited (“Metrion”), the specialist preclinical contract research organisation (CRO) and a leader in ion channel screening, today announced the appointment of Dr Chris Mathes, MBA, as Chief Commercial Officer (CCO). Chris will work alongside the Company’s expert leadership team to drive commercial strategy and lead global business development and marketing activities.

Metrion Biosciences enhances high-throughput screening services with access to Enamine compound libraries

11th April 2024

Metrion Biosciences Limited (“Metrion”), the specialist ion channel and cardiac safety screening contract research organisation (CRO) and drug discovery company, and Enamine Ltd (“Enamine”), the global leader in supplying small molecules and early drug discovery services, announced that Metrion has enhanced its High Throughput Screening (HTS) services with the addition of access to Enamine’s compound libraries.

Our Services

Metrion Biosciences Ion Channel Screening Icon Large 01

Ion Channel Screening

Metrion Biosciences Cardiac Safety Screening Icon Large 01 01

Cardiac Safety Screening

Metrion Biosciences Neuroscience Icon Large 01

Neuroscience

Metrion Biosciences Translational Assays Icon Large 01

Translational Assays

Metrion Biosciences Integrated Drug Discovery Icon Large 01 01

Integrated Drug Discovery

Metrion Upcoming Events Background scaled

News and Upcoming Events

Read news including equity financing, launch of GLP hERG Screening service, key appointments, collaboration with KCNC1 Foundation, High-Throughput Screening, expansion of ion channel screening services.

For media enquiries please email us here.

We hold and participate in numerous events each year for professional development, knowledge sharing, self-improvement and networking opportunities.

Please schedule a meeting with us to discuss any questions or any specific ion channel and assay requirements. We look forward to meeting you shortly.

Our DisPATCHes newsletter

Receive our latest news and insights to your inbox

The DisPATCHes newsletter delivers the latest ion channel, cardiac safety and neuroscience news from Metrion Biosciences.

Subscribe to DisPATCHes to receive the latest science insight, news, upcoming events, webinars, research findings, publications and more.

DisPATCHes newsletter
Wave Background thinner 01 1

Let’s work together

What are your specific ion channel and assay needs?

If you have any questions or would like to discuss your specific assay requirements, we will put you directly in touch with a member of our scientific team. Contact us today to discover more.